October 02, 2017
Sponsored by
SeraCare

Case Study: Development and Validation of Clinical ctDNA Cancer Assays

Partner Webinar

Join or Log in for Access

This content is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In this on-demand webinar, Tony Godfrey of the Boston University School of Medicine discusses how his lab is developing and validating clinical circulating tumor DNA assays.


View now to learn more about:


  • Background and potential of circulating tumor DNA as a cancer biomarker

  • Challenges and approaches for ctDNA detection

Sponsored by